nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4C—brainstem—narcolepsy	0.0624	0.203	CbGeAlD
Roflumilast—PDE4C—forebrain—narcolepsy	0.0602	0.196	CbGeAlD
Roflumilast—PDE4C—midbrain—narcolepsy	0.0398	0.129	CbGeAlD
Roflumilast—PDE4C—G alpha (s) signalling events—P2RY11—narcolepsy	0.0397	0.0573	CbGpPWpGaD
Roflumilast—PDE4D—G alpha (s) signalling events—P2RY11—narcolepsy	0.0346	0.0499	CbGpPWpGaD
Roflumilast—PDE4A—G alpha (s) signalling events—P2RY11—narcolepsy	0.0329	0.0475	CbGpPWpGaD
Roflumilast—PDE4B—G alpha (s) signalling events—P2RY11—narcolepsy	0.0305	0.044	CbGpPWpGaD
Roflumilast—PDE4B—forebrain—narcolepsy	0.028	0.0911	CbGeAlD
Roflumilast—PDE4C—brain—narcolepsy	0.025	0.0813	CbGeAlD
Roflumilast—PDE4D—brain—narcolepsy	0.022	0.0716	CbGeAlD
Roflumilast—PDE4B—medulla oblongata—narcolepsy	0.0202	0.0658	CbGeAlD
Roflumilast—PDE4A—brain—narcolepsy	0.0195	0.0634	CbGeAlD
Roflumilast—PDE4C—G alpha (s) signalling events—NPS—narcolepsy	0.0186	0.0268	CbGpPWpGaD
Roflumilast—PDE4B—midbrain—narcolepsy	0.0185	0.0601	CbGeAlD
Roflumilast—PDE4D—G alpha (s) signalling events—NPS—narcolepsy	0.0162	0.0234	CbGpPWpGaD
Roflumilast—PDE4A—G alpha (s) signalling events—NPS—narcolepsy	0.0154	0.0222	CbGpPWpGaD
Roflumilast—PDE4B—G alpha (s) signalling events—NPS—narcolepsy	0.0143	0.0206	CbGpPWpGaD
Roflumilast—PDE4B—brain—narcolepsy	0.0116	0.0378	CbGeAlD
Roflumilast—PDE4C—GPCR downstream signaling—HCRTR2—narcolepsy	0.00844	0.0122	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—HCRTR1—narcolepsy	0.00844	0.0122	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—P2RY11—narcolepsy	0.00815	0.0118	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HCRTR2—narcolepsy	0.00766	0.0111	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HCRTR1—narcolepsy	0.00766	0.0111	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—P2RY11—narcolepsy	0.0074	0.0107	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—HCRTR1—narcolepsy	0.00735	0.0106	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—HCRTR2—narcolepsy	0.00735	0.0106	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—P2RY11—narcolepsy	0.0071	0.0102	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00699	0.0101	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00699	0.0101	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—HCRT—narcolepsy	0.00693	0.01	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—P2RY11—narcolepsy	0.00675	0.00975	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HCRTR1—narcolepsy	0.00667	0.00963	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HCRTR2—narcolepsy	0.00667	0.00963	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00647	0.00934	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00647	0.00934	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—P2RY11—narcolepsy	0.00644	0.0093	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HCRTR2—narcolepsy	0.00635	0.00917	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HCRTR1—narcolepsy	0.00635	0.00917	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HCRT—narcolepsy	0.00629	0.00908	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—P2RY11—narcolepsy	0.00625	0.00902	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—PENK—narcolepsy	0.00618	0.00891	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—P2RY11—narcolepsy	0.00613	0.00885	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—HCRT—narcolepsy	0.00603	0.00871	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HCRTR2—narcolepsy	0.00588	0.00848	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HCRTR1—narcolepsy	0.00588	0.00848	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HCRT—narcolepsy	0.00574	0.00829	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—P2RY11—narcolepsy	0.00567	0.00819	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PENK—narcolepsy	0.00561	0.0081	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HCRT—narcolepsy	0.00548	0.00791	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PENK—narcolepsy	0.00538	0.00776	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HCRT—narcolepsy	0.00531	0.00767	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—TRH—narcolepsy	0.00525	0.00758	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HCRT—narcolepsy	0.00521	0.00753	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PENK—narcolepsy	0.00512	0.00739	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PENK—narcolepsy	0.00488	0.00705	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HCRT—narcolepsy	0.00483	0.00696	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—TRH—narcolepsy	0.00477	0.00688	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PENK—narcolepsy	0.00474	0.00684	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PENK—narcolepsy	0.00465	0.00671	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—HRH3—narcolepsy	0.00461	0.00665	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—TRH—narcolepsy	0.00457	0.0066	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HCRTR1—narcolepsy	0.00453	0.00653	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HCRTR2—narcolepsy	0.00453	0.00653	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—P2RY11—narcolepsy	0.00437	0.00631	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—TRH—narcolepsy	0.00435	0.00628	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PENK—narcolepsy	0.0043	0.00621	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HRH3—narcolepsy	0.00418	0.00604	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—TRH—narcolepsy	0.00415	0.00599	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—TRH—narcolepsy	0.00403	0.00581	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—HRH3—narcolepsy	0.00401	0.00579	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—TRH—narcolepsy	0.00395	0.0057	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HCRTR1—narcolepsy	0.00394	0.00569	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HCRTR2—narcolepsy	0.00394	0.00569	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—NPS—narcolepsy	0.00382	0.00551	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—TAC1—narcolepsy	0.00382	0.00551	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HRH3—narcolepsy	0.00382	0.00551	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—P2RY11—narcolepsy	0.00381	0.00549	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HCRTR1—narcolepsy	0.00375	0.00541	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HCRTR2—narcolepsy	0.00375	0.00541	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HCRT—narcolepsy	0.00372	0.00537	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—TRH—narcolepsy	0.00366	0.00528	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HRH3—narcolepsy	0.00364	0.00525	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—P2RY11—narcolepsy	0.00362	0.00523	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HRH3—narcolepsy	0.00353	0.0051	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HCRTR1—narcolepsy	0.00347	0.00501	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HCRTR2—narcolepsy	0.00347	0.00501	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HRH3—narcolepsy	0.00347	0.005	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—TAC1—narcolepsy	0.00347	0.005	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—NPS—narcolepsy	0.00347	0.005	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—P2RY11—narcolepsy	0.00335	0.00484	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—TAC1—narcolepsy	0.00332	0.00479	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—NPS—narcolepsy	0.00332	0.00479	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PENK—narcolepsy	0.00331	0.00478	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HCRT—narcolepsy	0.00324	0.00467	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HRH3—narcolepsy	0.00321	0.00463	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—NPS—narcolepsy	0.00316	0.00456	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—TAC1—narcolepsy	0.00316	0.00456	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HCRT—narcolepsy	0.00308	0.00445	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—TAC1—narcolepsy	0.00302	0.00435	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—NPS—narcolepsy	0.00302	0.00435	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—TAC1—narcolepsy	0.00293	0.00422	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—NPS—narcolepsy	0.00293	0.00422	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PENK—narcolepsy	0.00288	0.00416	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—NPS—narcolepsy	0.00287	0.00414	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—TAC1—narcolepsy	0.00287	0.00414	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HCRT—narcolepsy	0.00285	0.00411	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TRH—narcolepsy	0.00282	0.00407	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PENK—narcolepsy	0.00275	0.00396	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—TAC1—narcolepsy	0.00266	0.00383	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—NPS—narcolepsy	0.00266	0.00383	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PENK—narcolepsy	0.00254	0.00367	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HRH3—narcolepsy	0.00247	0.00357	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TRH—narcolepsy	0.00245	0.00354	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TRH—narcolepsy	0.00233	0.00337	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—HTR2A—narcolepsy	0.0023	0.00331	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TRH—narcolepsy	0.00216	0.00312	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HRH3—narcolepsy	0.00215	0.0031	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HTR2A—narcolepsy	0.00208	0.00301	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NPS—narcolepsy	0.00205	0.00295	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TAC1—narcolepsy	0.00205	0.00295	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HRH3—narcolepsy	0.00205	0.00295	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—HTR2A—narcolepsy	0.002	0.00288	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HTR2A—narcolepsy	0.0019	0.00275	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HRH3—narcolepsy	0.00189	0.00273	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HTR2A—narcolepsy	0.00181	0.00262	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NPS—narcolepsy	0.00178	0.00257	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TAC1—narcolepsy	0.00178	0.00257	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HTR2A—narcolepsy	0.00176	0.00254	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HTR2A—narcolepsy	0.00173	0.00249	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NPS—narcolepsy	0.0017	0.00245	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TAC1—narcolepsy	0.0017	0.00245	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HTR2A—narcolepsy	0.0016	0.00231	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TAC1—narcolepsy	0.00157	0.00227	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NPS—narcolepsy	0.00157	0.00227	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HTR2A—narcolepsy	0.00123	0.00178	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR2A—narcolepsy	0.00107	0.00155	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR2A—narcolepsy	0.00102	0.00147	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR2A—narcolepsy	0.000944	0.00136	CbGpPWpGaD
